QIAGEN Price to Sales Ratio 2010-2022 | QGEN
Historical PS ratio values for QIAGEN (QGEN) over the last 10 years. The current P/S ratio for QIAGEN as of February 03, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| QIAGEN P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-02-03 |
49.54 |
|
5.14 |
| 2022-09-30 |
41.28 |
$9.63 |
4.28 |
| 2022-06-30 |
47.20 |
$9.77 |
4.83 |
| 2022-03-31 |
49.00 |
$9.97 |
4.91 |
| 2021-12-31 |
55.58 |
$9.72 |
5.72 |
| 2021-09-30 |
51.68 |
$9.65 |
5.36 |
| 2021-06-30 |
48.38 |
$9.39 |
5.15 |
| 2021-03-31 |
48.69 |
$8.84 |
5.51 |
| 2020-12-31 |
52.85 |
$7.99 |
6.62 |
| 2020-09-30 |
52.26 |
$7.37 |
7.09 |
| 2020-06-30 |
42.81 |
$7.01 |
6.11 |
| 2020-03-31 |
41.60 |
$6.75 |
6.16 |
| 2019-12-31 |
33.80 |
$6.64 |
5.09 |
| 2019-09-30 |
32.97 |
$6.55 |
5.03 |
| 2019-06-30 |
40.55 |
$6.47 |
6.27 |
| 2019-03-31 |
40.68 |
$6.44 |
6.32 |
| 2018-12-31 |
34.45 |
$6.43 |
5.36 |
| 2018-09-30 |
37.88 |
$6.40 |
5.92 |
| 2018-06-30 |
36.16 |
$6.36 |
5.69 |
| 2018-03-31 |
32.31 |
$6.24 |
5.17 |
| 2017-12-31 |
30.93 |
$6.08 |
5.09 |
| 2017-09-30 |
31.50 |
$5.91 |
5.33 |
| 2017-06-30 |
33.53 |
$5.76 |
5.82 |
| 2017-03-31 |
28.97 |
$5.66 |
5.12 |
| 2016-12-31 |
29.10 |
$5.60 |
5.19 |
| 2016-09-30 |
28.50 |
$5.53 |
5.15 |
| 2016-06-30 |
22.65 |
$5.49 |
4.12 |
| 2016-03-31 |
23.20 |
$5.49 |
4.23 |
| 2015-12-31 |
28.71 |
$5.54 |
5.18 |
| 2015-09-30 |
26.81 |
$5.57 |
4.82 |
| 2015-06-30 |
25.74 |
$5.64 |
4.57 |
| 2015-03-31 |
26.17 |
$5.66 |
4.62 |
| 2014-12-31 |
24.36 |
$5.71 |
4.26 |
| 2014-09-30 |
23.65 |
$5.78 |
4.09 |
| 2014-06-30 |
25.39 |
$5.71 |
4.45 |
| 2014-03-31 |
21.90 |
$5.68 |
3.85 |
| 2013-12-31 |
24.73 |
$5.63 |
4.39 |
| 2013-09-30 |
22.22 |
$5.58 |
3.98 |
| 2013-06-30 |
20.68 |
$5.50 |
3.76 |
| 2013-03-31 |
21.89 |
$5.43 |
4.03 |
| 2012-12-31 |
18.85 |
$5.42 |
3.48 |
| 2012-09-30 |
19.22 |
$5.37 |
3.58 |
| 2012-06-30 |
17.34 |
$5.33 |
3.25 |
| 2012-03-31 |
16.17 |
$5.22 |
3.10 |
| 2011-12-31 |
14.34 |
$5.07 |
2.83 |
| 2011-09-30 |
14.36 |
$4.86 |
2.96 |
| 2011-06-30 |
19.75 |
$4.79 |
4.12 |
| 2011-03-31 |
20.82 |
$4.70 |
4.43 |
| 2010-12-31 |
20.30 |
$4.73 |
4.30 |
| 2010-09-30 |
18.42 |
$4.73 |
3.89 |
| 2010-06-30 |
19.96 |
$4.83 |
4.13 |
| 2010-03-31 |
23.87 |
$4.93 |
4.84 |
| 2009-12-31 |
23.19 |
$4.89 |
4.74 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$11.215B |
$2.252B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
